(Q42245777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Qing Xie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Deming Tan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Qin Ning

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Junqi Niu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xuefan Bai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rong Fan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Shijun Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jun Cheng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yanyan Yu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hao Wang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Min Xu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Guangfeng Shi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Mobin Wan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xinyue Chen

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hong Tang

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jifang Sheng

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xiaoguang Dou

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Junping Shi

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hong Ren

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Maorong Wang

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hongfei Zhang

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Zhiliang Gao

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Chengwei Chen

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hong Ma

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jidong Jia

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jinlin Hou

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

28 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1283-1292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24382690%20AND%20SRC:MED&resulttype=core&format=json

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

4 March 2020

cites work

1 reference

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

Management of chronic hepatitis B: experience from China.

21 January 2018

1 reference

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

21 January 2018

1 reference

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B

21 January 2018

1 reference

A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine.

21 January 2018

1 reference

Efficacy of entecavir switch therapy in chronic hepatitis B patients with incomplete virological response to telbivudine

21 January 2018

1 reference

Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy

21 January 2018

1 reference

The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir

21 January 2018

1 reference

Telbivudine versus lamivudine in patients with chronic hepatitis B

21 January 2018

1 reference

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

21 January 2018

1 reference

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

21 January 2018

1 reference

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

21 January 2018

1 reference

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

21 January 2018

1 reference

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

21 January 2018

1 reference

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

21 January 2018

1 reference

Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy

21 January 2018

1 reference

Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B.

21 January 2018

1 reference

Hepatitis B virus infection

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Hepatitis B virus infection

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Response to higher dose of entecavir 1.0 mg daily in patients with partial response to entecavir 0.5 mg daily

1 reference